Fredrik Piehl

1990–2026 年に発表

192
論文数
23,950
被引用数
82
h 指数
184
i10 指数

被引用数

Fredrik Piehl の年別被引用数1976 年: 被引用 2 件1991 年: 被引用 3 件1992 年: 被引用 3 件1993 年: 被引用 4 件1994 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 14 件1997 年: 被引用 17 件1998 年: 被引用 10 件1999 年: 被引用 20 件2000 年: 被引用 24 件2001 年: 被引用 28 件2002 年: 被引用 36 件2003 年: 被引用 44 件2004 年: 被引用 46 件2005 年: 被引用 45 件2006 年: 被引用 52 件2007 年: 被引用 34 件2008 年: 被引用 49 件2009 年: 被引用 36 件2010 年: 被引用 36 件2011 年: 被引用 20 件2012 年: 被引用 47 件2013 年: 被引用 52 件2014 年: 被引用 57 件2015 年: 被引用 75 件2016 年: 被引用 90 件2017 年: 被引用 110 件2018 年: 被引用 138 件2019 年: 被引用 735 件2020 年: 被引用 1,174 件2021 年: 被引用 1,385 件2022 年: 被引用 1,279 件2023 年: 被引用 1,009 件2024 年: 被引用 1,819 件2025 年: 被引用 939 件2026 年: 被引用 26 件1977〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,480 件、この内訳の 18.4%イギリス: 引用元論文 1,193 件、この内訳の 8.9%ドイツ: 引用元論文 1,010 件、この内訳の 7.5%イタリア: 引用元論文 883 件、この内訳の 6.6%スウェーデン: 引用元論文 853 件、この内訳の 6.3%中国: 引用元論文 825 件、この内訳の 6.1%カナダ: 引用元論文 515 件、この内訳の 3.8%スイス: 引用元論文 503 件、この内訳の 3.7%スペイン: 引用元論文 489 件、この内訳の 3.6%フランス: 引用元論文 452 件、この内訳の 3.4%オランダ: 引用元論文 443 件、この内訳の 3.3%オーストラリア: 引用元論文 397 件、この内訳の 3%
0%18.4%その他 25.4%

分野

  • Medicine62.9%
  • Neuroscience14%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Immunology and Microbiology6.8%
  • Engineering0.3%
  • Nursing0.3%
  • その他1.8%

トピック

  • Multiple Sclerosis Research Studies10.7%
  • Neuroinflammation and Neurodegeneration Mechanisms4%
  • Peripheral Neuropathies and Disorders3.8%
  • Amyotrophic Lateral Sclerosis Research3.6%
  • Alzheimer's disease research and treatments2.5%
  • T-cell and B-cell Immunology2.1%
  • その他73.3%

共著者

全論文

検索で開く
  1. Neurofilaments as biomarkers in neurological disorders

    著者: , , , , , , , , , , , , , - Nature Reviews Neurology 2018 被引用: 1,971

  2. Multiple sclerosis

    著者: , , , , , , - Nature Reviews Disease Primers 2018 被引用: 1,398

  3. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Damotte, Bertrand Fontaine, Léna Guillot‐Noël, Mark Lathrop, Sandra Vukusic, Achim Berthele, Viola Pongratz, Dorothea Buck, Christiane Gasperi, Christiane Graetz, Verena Grummel, Bernhard Hemmer, Muni Hoshi, Benjamin Knier, Thomas Korn, Christina M. Lill, Felix Luessi, Mark Mühlau, Frauke Zipp, Efthimios Dardiotis, Cristina Agliardi, Antonio Amoroso, Nadia Barizzone, Maria Donata Benedetti, Luisa Bernardinelli, Paola Cavalla, Ferdinando Clarelli, Gıancarlo Comı, Daniele Cusi, Federica Esposito, Laura Ferrè, Daniela Galimberti, Clara Guaschino, Maurizio Leone, Vittorio Martinelli, Lucia Moiola, Marco Salvetti, Melissa Sorosina, Domizia Vecchio, Andrea Zauli, Silvia Santoro, Nicasio Mancini, Miriam Zuccalà, Julia Mescheriakova, Cornelia M. van Duijn, Steffan D. Bos, Elisabeth Gulowsen Celius, Anne Spurkland, Manuel Comabella, Xavier Montalbán, Lars Alfredsson, Izaura Lima Bomfim, David Gómez-Cabrero, Jan Hillert, Maja Jagodic, Magdalena Lindén, Fredrik Piehl, Ilijas Jelčić, Roland Martinꝉ, Mirela Sospedra, Amie Baker, Maria Ban, Clive Hawkins, Pirro G. Hysi, Seema Kalra, Fredrik Karpe, Jyoti Khadake, Geneviève Lachance, Paul Molyneux, Matthew Neville ほか 57 名 - Science 2019 被引用: 1,456

  4. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefanie Aeschbacher, Muhamed Barakovic, Andreas Buser, Andrew Chan, Giulio Disanto, Marcus D'Souza, Renaud Du Pasquier, Oliver Findling, Riccardo Galbusera, Kevin Hrusovsky, Michael Khalil, Johannes Lorscheider, Amandine Mathias, Annette Orleth, Ernst-Wilhelm Radue, Reza Rahmanzadeh, Tim Sinnecker, Suvitha Subramaniam, Jochen Vehoff, Sven Wellmann, Jens Wuerfel, Chiara Zecca - The Lancet Neurology 2022 被引用: 601

  5. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Jonsson, Ludwig Kappos, Mohsen Khademi, Michael Khalil, Jens Kühle, Mikael Landén, Ville Leinonen, Giancarlo Logroscino, Ching‐Hua Lu, Jan Lycke, Nadia Magdalinou, Andrea Malaspina, Niklas Mattsson, Lieke Meeter, Sanjay R. Mehta, Signe Modvig, Tomas Olsson, Ross W. Paterson, Josué Pérez‐Santiago, Fredrik Piehl, Yolande A.L. Pijnenburg, Okko T. Pyykkö, Óskar Ragnarsson, Julio C. Rojas, Jeppe Romme Christensen, Linda Sandberg, Carole Scherling, Jonathan M. Schott, Finn Sellebjerg, Isabella Laura Simone, Tobias Skillbäck, Morten Stilund, Peter Sundström, Anders Svenningsson, Rosanna Tortelli, Carla Tortorella, Alessandro Trentini, Maria Troiano, Martin R. Turner, John C. van Swieten, Mattias Vågberg, Marcel M. Verbeek, Luisa María Villar, Pieter Jelle Visser, Anders Wallin, Andreas Weiss, Carsten Wikkelsø, Edward J. Wild - JAMA Neurology 2019 被引用: 760

  6. Neurofilaments as biomarkers in neurological disorders — towards clinical application

    著者: , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Neurology 2024 被引用: 372

  7. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fredrik Piehl, Marco Battaglini, Urs Fischer, Ludwig Kappos, Claudio Gobbi, Cristina Granziera, Claire Bridel, David Leppert, Aleksandra Maleska Maceski, Pascal Benkert, Jens Kühle - JAMA Neurology 2023 被引用: 275

  8. Locus for severity implicates CNS resilience in progression of multiple sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gıancarlo Comı, Chris Cotsapas, Bruce Cree, Sandra D’Alfonso, Efthimios Dardiotis, Philip L. De Jager, Silvia Delgado, Bénédicte Dubois, Sinah Engel, Federica Esposito, Marzena J. Fabis‐Pedrini, Massimo Filippi, Kathryn C. Fitzgerald, Christiane Gasperi, Lissette Gomez, Refujia Gomez, Georgios M. Hadjigeorgiou, Jörg Hamann, Friederike Held, Roland G. Henry, Jan Hillert, Jesse Huang, Inge Huitinga, Talat Islam, Noriko Isobe, Maja Jagodic, Allan G. Kermode, Michael Khalil, Trevor J. Kilpatrick, Ioanna Konidari, Karim L. Kreft, Jeannette Lechner‐Scott, Maurizio Leone, Felix Luessi, Sunny Malhotra, Ali Manouchehrinia, Clara P. Manrique, Filippo Martinelli Boneschi, Andrea C. Martinez, Viviana Martínez-Maldonado, Elisabetta Mascia, Luanne M. Metz, Luciana Midaglia, Xavier Montalbán, Jorge R. Oksenberg, Tomas Olsson, Annette Oturai, Kimmo Pääkkönen, Grant P. Parnell, Nikolaos A. Patsopoulos, Margaret A. Pericak‐Vance, Fredrik Piehl, Justin P. Rubio, Adam Santaniello, Silvia Santoro, Catherine Schaefer, Finn Sellebjerg, Hengameh Shams, Klementy Shchetynsky, Cláudia Silva, Vasileios Siokas, Helle Bach Søndergaard, Melissa Sorosina, Bruce Taylor, Marijne Vandebergh, Elena S. Vasileiou, Domizia Vecchio, Margarete M. Voortman, Howard L. Weiner, Dennis Wever ほか 21 名 - Nature 2023 被引用: 227

  9. Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2018 被引用: 523

  10. Confounding effect of blood volume and body mass index on blood neurofilament light chain levels

    著者: , , , , , , - Annals of Clinical and Translational Neurology 2020 被引用: 247

  11. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alasdair Coles, Jan Hillert, Fredrik Piehl, Helmut Butzkueven, Tomáš Kalinčík - The Lancet Neurology 2020 被引用: 438

  12. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jerrica Farias, Rita Frangiomore, Sarah Heintsman, Robert H.P. de Meel, Manisha Chopra, Paolo Emilio Alboini, Angela Genge - Neurology 2019 被引用: 288

  13. Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

    著者: , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2022 被引用: 194

  14. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

    著者: , , , , , , , , , , , , , , , - JAMA Neurology 2019 被引用: 509

  15. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

    著者: , , , , , , , , , , , - Neurology 2017 被引用: 428

  16. Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis

    著者: , , , , , , , , , - JAMA Neurology 2021 被引用: 234

  17. Risk factors for amyotrophic lateral sclerosis

    著者: , , , , - Clinical Epidemiology 2015 被引用: 454

  18. Inflammation-related plasma and CSF biomarkers for multiple sclerosis

    著者: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 被引用: 197

  19. Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis

    著者: , , , , , , , , , , , , , , - Nature Communications 2023 被引用: 94

  20. Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ann Herman, Christopher Harp, Amit Bar‐Or - JAMA Neurology 2024 被引用: 92

  21. T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression

    著者: , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 109

  22. Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2022 被引用: 124

  23. DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisabeth Gulowsen Celius, Helle Bach Søndergaard, Jesper Tegnér, Hanne F. Harbo, Annette Oturai, Sigurgeir Ólafsson, Hannes P. Eggertsson, Bjarni V. Halldórsson, Haukur Hjaltason, Elías Ólafsson, Ingileif Jónsdóttir, Kāri Stefánsson, Tomas Olsson, Fredrik Piehl, Tomas J. Ekström, Ingrid Kockum, Andrew P. Feinberg, Maja Jagodic - Nature Communications 2018 被引用: 212

  24. Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

    著者: , , , , , , , , , , , , , , , , - Nature Communications 2019 被引用: 142